{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T08:15:49Z","timestamp":1783498549845,"version":"3.55.0"},"reference-count":34,"publisher":"Wiley","license":[{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:00:00Z","timestamp":1783468800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. pediatr. gastroenterol. nutr."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Sarcopenia is prevalent in pediatric liver disease and inflammatory bowel disease (IBD) and predicts adverse outcomes. We aimed to compare sarcopenia prevalence in pediatric primary sclerosing cholangitis (PSC)\u2010colitis versus non\u2010PSC colitis, characterize longitudinal anthropometric trajectories, and examine the association between sarcopenia and liver outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective study compared children with PSC\u2010colitis to matched non\u2010PSC colitis controls. Total psoas muscle area (tPMA) was measured on magnetic resonance enterography. Sarcopenia was defined as tPMA &lt;3rd percentile. Logistic regression examined the PSC\u2010sarcopenia association adjusting for IBD factors. Anthropometric and gamma\u2010glutamyl transferase (GGT) trajectories were analyzed using linear mixed\u2010effects models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 85 patients (31 PSC\u2010colitis, 54 non\u2010PSC colitis), sarcopenia prevalence was 42% versus 26%. After adjustment, PSC\u2010colitis patients had nearly fivefold higher odds of sarcopenia (adjusted odds ratio [aOR] 4.81, 95% confidence interval [CI] 1.33\u201317.36,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.016). However, height\u2010corrected tPMA was similar between groups (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.97), and the PSC\u2010sarcopenia association attenuated when adjusting for height (aOR 3.16,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.085). Sarcopenic PSC\u2010colitis patients demonstrated weight recovery yet persistent height deficits. Sarcopenic non\u2010PSC colitis patients had persistent weight deficits without height impairment. GGT trajectories in PSC\u2010colitis did not differ by sarcopenia status.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Sarcopenia in PSC\u2010colitis may reflect proportionate growth impairment, \u201cshort but not skinny,\u201d rather than catabolic wasting. This phenotype, characterized by persistent height deficits despite weight recovery and mild colitis, may suggest hepatobiliary or other mechanisms distinct from the gut inflammation\u2010driven sarcopenia in non\u2010PSC colitis and the cachexia of end\u2010stage liver disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/jpn3.70499","type":"journal-article","created":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T07:41:52Z","timestamp":1783496512000},"source":"Crossref","is-referenced-by-count":0,"title":["Short, not skinny: The distinct sarcopenia phenotype of pediatric primary sclerosing cholangitis\u2010inflammatory bowel disease"],"prefix":"10.1002","author":[{"given":"Ghaida","family":"Dahlwi","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Faculty of Medicine King Abdulaziz University Jeddah Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Yodoshi","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology, and Nutrition, The Hospital for Sick Children University of Toronto Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E. M.","family":"O'Donnell","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology, and Nutrition, The Hospital for Sick Children University of Toronto Toronto Ontario Canada"},{"name":"Discipline of Paediatrics, School of Clinical Medicine, UNSW Medicine and Health Sydney New South Wales Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Hadian","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Imaging, The Hospital for Sick Children University of Toronto Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Griffiths","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology, and Nutrition, The Hospital for Sick Children University of Toronto Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Church","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology, and Nutrition, The Hospital for Sick Children University of Toronto Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9538-3005","authenticated-orcid":false,"given":"Amanda","family":"Ricciuto","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Hepatology, and Nutrition, The Hospital for Sick Children University of Toronto Toronto Ontario Canada"},{"name":"Child Health Evaluative Sciences, SickKids Research Institute, Institute of Health Policy, Management and Evaluation University of Toronto Toronto Ontario Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,7,8]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/hep.29204","article-title":"The natural history of primary sclerosing cholangitis in 781 children: a multicenter, international collaboration","volume":"66","author":"Deneau MR","year":"2017","journal-title":"Hepatology"},{"key":"e_1_2_9_3_1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11894-018-0620-2","article-title":"The IBD and PSC phenotypes of PSC\u2010IBD","volume":"20","author":"Ricciuto A","year":"2018","journal-title":"Curr Gastroenterol Rep"},{"key":"e_1_2_9_4_1","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.cgh.2019.08.048","article-title":"Primary sclerosing cholangitis in children with inflammatory bowel diseases is associated with milder clinical activity but more frequent subclinical inflammation and growth impairment","volume":"18","author":"Ricciuto A","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"e_1_2_9_5_1","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/liv.15108","article-title":"Sarcopenia is highly prevalent in children with autoimmune liver diseases and is linked to visceral fat and parent\u2010perceived general health","volume":"42","author":"Amevor AA","year":"2022","journal-title":"Liver Int"},{"key":"e_1_2_9_6_1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12876-024-03232-9","article-title":"Imaging\u2010based diagnosis of sarcopenia for transplant\u2010free survival in primary sclerosing cholangitis","volume":"24","author":"Keshoofi P","year":"2024","journal-title":"BMC Gastroenterol"},{"key":"e_1_2_9_7_1","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s11604-022-01283-0","article-title":"Clinical utility of computed tomography\u2010based evaluation of trunk muscles in primary sclerosing cholangitis","volume":"40","author":"Kikuchi Y","year":"2022","journal-title":"Jpn J Radiol"},{"key":"e_1_2_9_8_1","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70328","article-title":"Sarcopenia\u2014A valuable imaging biomarker for disease progression in patients with primary sclerosing cholangitis (PSC)?","volume":"45","author":"Levers A","year":"2025","journal-title":"Liver Int"},{"key":"e_1_2_9_9_1","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.clnesp.2023.08.009","article-title":"Systematic review: sarcopenia in paediatric inflammatory bowel disease","volume":"57","author":"Aljilani B","year":"2023","journal-title":"Clin Nutr ESPEN"},{"key":"e_1_2_9_10_1","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/MPG.0000000000003091","article-title":"Sarcopenia is a predictor for adverse clinical outcome in pediatric inflammatory bowel disease","volume":"72","author":"Atlan L","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"e_1_2_9_11_1","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","article-title":"Consensus definition of sarcopenia, cachexia and pre\u2010cachexia: joint document elaborated by Special Interest Groups (SIG) \u201ccachexia\u2010anorexia in chronic wasting diseases\u201d and \u201cnutrition in geriatrics","volume":"29","author":"Muscaritoli M","year":"2010","journal-title":"Clin Nutr"},{"key":"e_1_2_9_12_1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon K","year":"2011","journal-title":"Lancet Oncol"},{"key":"e_1_2_9_13_1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/jcsm.12514","article-title":"Paediatric reference values for total psoas muscle area","volume":"11","author":"Lurz E","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_9_14_1","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1002\/jcsm.13049","article-title":"Reference values for MRI\u2010derived psoas and paraspinal muscles and macroscopic fat infiltrations in paraspinal muscles in children","volume":"13","author":"Marunowski K","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_9_15_1","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/hep4.1251","article-title":"Gamma glutamyltransferase reduction is associated with favorable outcomes in pediatric primary sclerosing cholangitis","volume":"2","author":"Deneau MR","year":"2018","journal-title":"Hepatol Commun"},{"key":"e_1_2_9_16_1","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1002\/hep.31393","article-title":"The sclerosing cholangitis outcomes in pediatrics (SCOPE) index: a prognostic tool for children","volume":"73","author":"Deneau MR","year":"2021","journal-title":"Hepatology"},{"key":"e_1_2_9_17_1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1093\/ecco-jcc\/jjz106","article-title":"Phenotypic variation in paediatric inflammatory bowel disease by age: a multicentre prospective inception cohort study of the canadian children IBD network","volume":"14","author":"Dhaliwal J","year":"2020","journal-title":"J Crohns Colitis"},{"key":"e_1_2_9_18_1","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/lt.26027","article-title":"Higher mortality in pediatric liver transplant candidates with sarcopenia","volume":"27","author":"Boster JM","year":"2021","journal-title":"Liver Transpl"},{"key":"e_1_2_9_19_1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2147\/HMER.S348888","article-title":"Perspectives on sarcopenia as a predictor for outcomes in pediatric patients with chronic liver disease","volume":"14","author":"Chen C","year":"2022","journal-title":"Hepatic Med Evid Res"},{"key":"e_1_2_9_20_1","first-page":"171","article-title":"Impact of sarcopenia on clinical outcomes in pediatric chronic liver disease post\u2010liver transplantation: prevalence and implications","volume":"17","author":"Pourjafar S","year":"2024","journal-title":"Gastroenterol Hepatol Bed Bench"},{"key":"e_1_2_9_21_1","first-page":"12","article-title":"Growth hormone resistance in chronic inflammation: the role of cytokines","volume":"86","author":"Wong SC","year":"2016","journal-title":"Horm Res Paediatr"},{"key":"e_1_2_9_22_1","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1002\/jpn3.70210","article-title":"Growth hormone resistance in children with chronic cholestatic liver disease and reduced skeletal muscle mass","volume":"81","author":"Boster JM","year":"2025","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"e_1_2_9_23_1","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0022-3476(05)81079-0","article-title":"Resistance to the growth\u2010promoting and metabolic effects of growth hormone in children with chronic liver disease","volume":"117","author":"Bucuvalas JC","year":"1990","journal-title":"J Pediatr"},{"key":"e_1_2_9_24_1","doi-asserted-by":"crossref","first-page":"G986","DOI":"10.1152\/ajpgi.00287.2004","article-title":"Alterations in growth hormone receptor abundance regulate growth hormone signaling in murine obstructive cholestasis","volume":"288","author":"Held MA","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"e_1_2_9_25_1","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/jbmr.1961","article-title":"Positive regulation of osteogenesis by bile acid through FXR","volume":"28","author":"Cho SW","year":"2013","journal-title":"J Bone Miner Res"},{"key":"e_1_2_9_26_1","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1002\/jcsm.12798","article-title":"Bile acid metabolism dysregulation associates with cancer cachexia: roles of liver and gut microbiome","volume":"12","author":"Feng L","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"e_1_2_9_27_1","first-page":"2025","article-title":"Bile acid signaling in skeletal muscle homeostasis: from molecular mechanisms to clinical applications","volume":"16","author":"Jia F","year":"2025","journal-title":"Front Endocrinol"},{"key":"e_1_2_9_28_1","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1200\/JCO.2012.45.2722","article-title":"Cancer cachexia in the age of obesity: skeletal muscle depletion is a powerful prognostic factor, independent of body mass index","volume":"31","author":"Martin L","year":"2013","journal-title":"J Clin Oncol"},{"key":"e_1_2_9_29_1","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care","volume":"33","author":"Mourtzakis M","year":"2008","journal-title":"Appl Physiol Nutr Metab"},{"key":"e_1_2_9_30_1","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20211094","article-title":"Assessment of anterior thigh muscle size and fat infiltration using single\u2010slice CT imaging versus automated MRI analysis in adults","volume":"95","author":"Niklasson E","year":"2022","journal-title":"Br J Radiol"},{"key":"e_1_2_9_31_1","doi-asserted-by":"crossref","first-page":"4053","DOI":"10.1007\/s00330-020-07440-1","article-title":"Skeletal muscle mass and sarcopenia can be determined with 1.5\u2010T and 3\u2010T neck MRI scans, in the event that no neck CT scan is performed","volume":"31","author":"Zwart AT","year":"2021","journal-title":"Eur Radiol"},{"key":"e_1_2_9_32_1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222042","article-title":"Reliable and robust method for abdominal muscle mass quantification using CT\/MRI: an explorative study in healthy subjects","volume":"14","author":"Park J","year":"2019","journal-title":"PLoS One"},{"key":"e_1_2_9_33_1","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz\u2010Jentoft AJ","year":"2019","journal-title":"Age Ageing"},{"key":"e_1_2_9_34_1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/(SICI)1096-8644(199706)103:2<157::AID-AJPA2>3.0.CO;2-R","article-title":"Whole body bone, fat and lean mass in children: comparison of three ethnic groups","volume":"103","author":"Nelson DA","year":"1997","journal-title":"Am J Phys Anthropol"},{"key":"e_1_2_9_35_1","first-page":"1414","article-title":"Defining normal ranges of skeletal muscle area and skeletal muscle index in children on CT using an automated deep learning pipeline","volume":"217","author":"Metzger GA","year":"2021","journal-title":"Am J Roentgenol"}],"container-title":["Journal of Pediatric Gastroenterology and Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jpn3.70499","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jpn3.70499","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jpn3.70499","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T07:41:57Z","timestamp":1783496517000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jpn3.70499"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,8]]},"references-count":34,"alternative-id":["10.1002\/jpn3.70499"],"URL":"https:\/\/doi.org\/10.1002\/jpn3.70499","archive":["Portico"],"relation":{},"ISSN":["0277-2116","1536-4801"],"issn-type":[{"value":"0277-2116","type":"print"},{"value":"1536-4801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,8]]},"article-number":"jpn3.70499"}}